October 30th 2024
The alliance’s president discusses the current state of data sharing, security concerns, and the adoption AI.
Optimizing the Digital Opportunity in Biopharmaceutical R&D
July 24th 2018If advanced technologies hold the key to at least some of the productivity issues R&D organizations need to overcome, Nicholas Lakin asks what are the best strategies and operating models for exploiting these aids to their fullest potential.
The Fundamental Disconnect Between Pharma and Technology
May 23rd 2018Otsuka Pharmaceutical’s President and CEO of Development and Commercialization William Carson explains the initial growing pains the company went through with their technology company partner in the early development stages of the first U.S. FDA approved digital medicine system.